Tier 3 · Filer Universe

Karyopharm Therapeutics Inc.

KPTI · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$1.99
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001503802
Liquidity rank
#3317
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$146.07M2025-12-310001193125-26-049397
Annual diluted EPS-17.932025-12-310001193125-26-049397
Quarterly revenue$35.07M2026-03-310001193125-26-222827
Quarterly diluted EPS-1.242026-03-310001193125-26-222827

SEC EDGAR Frames batch generated 2026-08-10T23:34:18.958Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqDHR · Tier 1 peerABT · Tier 1 peerBMY · Tier 1 peerTMO · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames